Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation
|
Homology Medicines, Inc. (FIXX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/20/2023 |
4/A
| Blum Michael Lee (Chief Commercial Officer) has filed a Form 4 on Homology Medicines, Inc. |
01/20/2023 |
4/A
| Alloway Paul (See Remarks) has filed a Form 4 on Homology Medicines, Inc. |
01/20/2023 |
4/A
| Seymour Albert (See Remarks) has filed a Form 4 on Homology Medicines, Inc. |
09/08/2021 |
4/A
| Kelly Timothy P (See Remarks) has filed a Form 4 on Homology Medicines, Inc.
Txns:
| Sold 6,232 shares
@ $11.1622, valued at
$69.6k
|
|
06/11/2019 |
4/A
| Wheeler Cameron (Director) has filed a Form 4 on Homology Medicines, Inc.
Txns:
| Granted 15,580 options to buy
@ $19.51, valued at
$304k
|
|
05/16/2018 |
4/A
| SHAH MAHENDRA (Director) has filed a Form 4 on Homology Medicines, Inc.
Txns:
| Granted 250,000 shares
@ $16, valued at
$4M
|
|
04/04/2018 |
4/A
| PARMAR KUSH (10% Owner) has filed a Form 4 on Homology Medicines, Inc.
Txns:
| Converted 5,392,037 shares
@ $0 |
|
|
|